Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 11 Nov 2022

Data mining and safety analysis of BTK inhibitors: A pharmacovigilance investigation based on the FAERS database

in Drugs Outcomes Research and Policies

Qing Wan
Qiang Li
Xin Lai
Tiantian Xu
Jinfang Hu
Hongwei Peng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.995522

7,186 views
15 citations

Original Research

Published on 10 Nov 2022

Efficacy and safety of platelet-rich plasma in the treatment of carpal tunnel syndrome: A network meta-analysis of different injection treatments

in Drugs Outcomes Research and Policies

Pan Hong
Yu Zheng
Saroj Rai
Yuhong Ding
Yeming Zhou
Ruikang Liu
Jin Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.906075

5,045 views
7 citations

Systematic Review

Published on 10 Nov 2022

Antioxidant therapy for patients with oral lichen planus: A systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Jie Bao
Chu Chen
Jiayu Yan
Yueqiang Wen
Jiamin Bian
Mengting Xu
Qin Liang
Qingmei He

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1030893

4,849 views
7 citations

Original Research

Published on 10 Nov 2022

Risk prediction model of polypharmacy for community-dwelling elderly patients: An assessment tool for early detection

in Drugs Outcomes Research and Policies

Qi Tang
Jing Lu
Wenhui Wu
Zhenwei Liu
Sitang Zhao
Chengyue Li
Gang Chen
Jun Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.977492

2,208 views
1 citation

Systematic Review

Published on 10 Nov 2022

A comprehensive comparison of medication strategies for platinum-sensitive recurrent ovarian cancer: A Bayesian network meta-analysis

in Drugs Outcomes Research and Policies

Yuanzhi Liu
Yilan Huang
Jingyan Li
Shengli Wan
Nan Jiang
Jie Yang
Sawitree Chiampanichayakul
Singkome Tima
Songyot Anuchapreeda
Jianming Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1010626

3,356 views
5 citations

Clinical Trial

Published on 09 Nov 2022

Multicenter, randomized controlled trial of traditional Japanese medicine, kakkonto with shosaikotokakikyosekko, for mild and moderate coronavirus disease patients

in Drugs Outcomes Research and Policies

Shin Takayama
Takao Namiki
Ryutaro Arita
Rie Ono
Akiko Kikuchi
Minoru Ohsawa
Natsumi Saito
Satoko Suzuki
Hajime Nakae
Seiichi Kobayashi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1008946

16,373 views
12 citations

Original Research

Published on 09 Nov 2022

Do antibody–drug conjugates increase the risk of sepsis in cancer patients? A pharmacovigilance study

in Drugs Outcomes Research and Policies

Shuang Xia
Yi-Chang Zhao
Lin Guo
Hui Gong
Yi-Kun Wang
Rui Ma
Bi-Kui Zhang
Yue Sheng
Mayur Sarangdhar
Yoshihiro Noguchi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.967017

5,261 views
9 citations

Original Research

Published on 09 Nov 2022

Artificial intelligence-based internet hospital pharmacy services in China: Perspective based on a case study

in Drugs Outcomes Research and Policies

Fengjiao Bu
Hong Sun
Ling Li
Fengmin Tang
Xiuwen Zhang
Jingchao Yan
Zhengqiang Ye
Taomin Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1027808

8,458 views
22 citations

Original Research

Published on 09 Nov 2022

Institutionalizing health technology assessment in Egypt: Situational analysis and roadmap

in Drugs Outcomes Research and Policies

Pilar Pinilla-Dominguez
Shorouk Taha
Hugh McGuire
Ahmed Elagamy
Amal Sedrak
Mary Gamal
Mariam Eldebeiky
Dalia Dawoud

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1014658

6,210 views
5 citations

Original Research

Published on 08 Nov 2022

Survival analyses of the ZeOxaNMulti trial: Follow-up randomized, double-blinded, placebo-controlled trial of oral PMA-zeolite to prevent chemotherapy-induced side effects, especially peripheral neuropathy

in Drugs Outcomes Research and Policies

Maria Giuseppa Vitale
Anna Crispo
Dario Arundine
Riccardo Ronga
Carmela Barbato
Assunta Luongo
Francesco Habetswallner
Bernardo Maria De Martino
Angela Maione
Sandra Eisenwagen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.874028

1,873 views
1 citation

Systematic Review

Published on 07 Nov 2022

Comparison of seven cyclosporine A formulations for dry eye disease: A systematic review and network meta-analysis

in Drugs Outcomes Research and Policies

Dongyang Gao
Zhuoli Da
Kan Yang
Yuanyuan Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.882803

8,161 views
9 citations

General Commentary

Published on 03 Nov 2022

Commentary: Predicting blood concentration of tacrolimus in patients with autoimmune diseases using machine learning techniques based on real-world evidence

in Drugs Outcomes Research and Policies

Yuxiang Zhu
Xuebin Wang
Xue Wang
Lizhi Chen
Zhuo Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1000476

1,374 views
1 citation

Original Research

Published on 03 Nov 2022

Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement

in Drugs Outcomes Research and Policies

Nancy Ngum
Jane Mashingia
Margareth Ndomondo-Sigonda
Stuart Walker
Sam Salek

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1031289

1,855 views
5 citations

Original Research

Published on 31 Oct 2022

Clinical features, diagnosis and management of amoxicillin-induced Kounis syndrome

in Drugs Outcomes Research and Policies

Chunjiang Wang
Yulu Zhou
Weijin Fang
Zuojun Li
Shaoli Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.998239

4,121 views
2 citations

Systematic Review

Published on 28 Oct 2022

Rituximab for the treatment of connective tissue disease–associated interstitial lung disease: A systematic review and meta-analysis

in Drugs Outcomes Research and Policies

Linrui Xu
Faping Wang
Fengming Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1019915

5,416 views
7 citations

Original Research

Published on 28 Oct 2022

Comprehensibility of a personalized medication overview compared to usual-care prescription drug labels

in Drugs Outcomes Research and Policies

Laura Schackmann
Liset van Dijk
Anne E. M. Brabers
Sandra Zwier
Ellen S. Koster
Marcia Vervloet

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1004830

2,296 views
1 citation

Navigation group

Articles

Data mining and safety analysis of BTK inhibitors: A pharmacovigilance investigation based on the FAERS database

Efficacy and safety of platelet-rich plasma in the treatment of carpal tunnel syndrome: A network meta-analysis of different injection treatments

Antioxidant therapy for patients with oral lichen planus: A systematic review and meta-analysis

Risk prediction model of polypharmacy for community-dwelling elderly patients: An assessment tool for early detection

A comprehensive comparison of medication strategies for platinum-sensitive recurrent ovarian cancer: A Bayesian network meta-analysis

Multicenter, randomized controlled trial of traditional Japanese medicine, kakkonto with shosaikotokakikyosekko, for mild and moderate coronavirus disease patients

Do antibody–drug conjugates increase the risk of sepsis in cancer patients? A pharmacovigilance study

Artificial intelligence-based internet hospital pharmacy services in China: Perspective based on a case study

Institutionalizing health technology assessment in Egypt: Situational analysis and roadmap

Survival analyses of the ZeOxaNMulti trial: Follow-up randomized, double-blinded, placebo-controlled trial of oral PMA-zeolite to prevent chemotherapy-induced side effects, especially peripheral neuropathy

Comparison of seven cyclosporine A formulations for dry eye disease: A systematic review and network meta-analysis

Commentary: Predicting blood concentration of tacrolimus in patients with autoimmune diseases using machine learning techniques based on real-world evidence

Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement

Clinical features, diagnosis and management of amoxicillin-induced Kounis syndrome

Rituximab for the treatment of connective tissue disease–associated interstitial lung disease: A systematic review and meta-analysis

Comprehensibility of a personalized medication overview compared to usual-care prescription drug labels